Navigation Links
Gardasil Vaccine Guards Against HPV in Boys
Date:2/3/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Feb. 2 (HealthDay News) -- A large international trial finds that the Gardasil vaccine shields young men from human papillomavirus (HPV) as well as it protects young women.

HPV is the leading cause of cervical cancer in women, but also has been linked to penile cancer and other malignancies in men.

According to a study in the Feb. 3 issue of the New England Journal of Medicine, which was funded by the vaccine's maker, Merck & Co., Gardasil was 90 percent effective in older teenaged boys and young men.

"Studies like this underscore the 'human' in human papillomavirus," said Fred Wyand, director of the HPV Resource Center at the American Social Health Association. "This well-designed study reinforces the idea that there is value in vaccinating young men against a virus that is nearly ubiquitous among sexually active individuals."

Gardasil protects against several strains of HPV, which is the leading cause of cervical cancer in women. It has also been linked to vulvar, anal and throat cancers. Studies have shown it to be about 100 percent effective in preventing precancerous cervical lesions in females.

The U.S. Food and Drug Administration approved the vaccine for girls in 2008 and for boys aged 9 through 26 in 2009. Although the U.S. Centers for Disease Control and Prevention recommends that 11- and 12-year-old girls begin receiving the vaccine as part of school vaccination efforts, an advisory panel voted against routine use of the vaccine in boys and men.

Uptake of the vaccine, which costs about $375, has been far from universal among girls. According to a study presented last year by researchers at the University of Maryland, just one-third of teen girls and young women who start the three-dose series actually finish, and almost three-quarters don't start it at all.

But study author Anna Giuliano believes that, "vaccinating males would have a direct benefit that men would receive, as well as a community benefit. If you reduce infections in men, you're going to reduce transmission to their partners so you have the herd immunity effect."

HPV is almost ubiquitous in males and females, but experts note that most people will clear the virus naturally so that it does not result in any harm.

This study involved more than 4,000 boys and men aged 16-to-26 from 18 different countries who were randomly assigned to get the vaccine or not. All were HPV-free at the beginning of the trial, and were followed for about three years.

Among participants who completed the three-vaccine series, Gardasil afforded 90 percent protection against HPV.

"It's a similar efficacy to what we've seen in females," said Giuliano, who is chair of cancer epidemiology and genetics at the H. Lee Moffitt Cancer Center in Tampa.

The researchers also saw some reduction in the number of precancerous penile lesions, although at this point they said it's impossible to know whether this will result in a lower rate of penile cancers.

"We're going to finally be able to see men benefit from vaccine, as women have, in coming years," said Giuliano.

More information

The U.S. Centers for Disease Control and Prevention has more on HPV.

SOURCES: Anna Giuliano, Ph.D., chair, cancer epidemiology and genetics, H. Lee Moffitt Cancer Center, Tampa; Fred Wyand, director, HPV Resource Center, American Social Health Association; Feb. 3, 2011, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vaccine May Prevent TB in People With HIV
2. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
3. New strategy produces promising advance in cancer vaccines
4. Screens, Vaccine for HPV Less Beneficial in Older Women
5. New Technology Could Widen Reach of Vaccines
6. Texas-based consortium announces groundbreaking vaccine research program
7. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
8. Possible vaccine for mesothelioma proven safe
9. Groundbreaking research to find vaccine for hepatitis C
10. Vaccine for Asbestos-Related Cancer Looks Safe
11. CDC Awards Abt Associates Additional Contracts to Evaluate Effectiveness of H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gardasil Vaccine Guards Against HPV in Boys
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology: